Article
Intron-Retention Neoantigen Load Predicts Favorable Prognosis in Pancreatic Cancer.
JCO clinical cancer informatics - 1 Feb 2022
Dong Chuanpeng, Reiter Jill L, Dong Edward, Wang Yue, Lee Kelvin P, Lu Xiongbin, Liu Yunlong
Abstract excerpt
PURPOSE: High tumor mutation burden (TMB) in many cancer types is associated with the production of tumor-specific neoantigens, a favorable outcome and response to immune checkpoint blockade (ICB) therapy. Besides mutation-derived neoantigens, aberrant intron retention also produces tumor neopeptides that could trigger an immune response. The relationship between intron-retention-derived tumor neoantigens...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
